Podcasts about IRB

Dr. Kellie Owens, is an assistant professor in the section of medical ethics at NYU Grossman School of Medicine. She's a sociologist and empirical bioethicist studying how digital technologies are woven into the fabric of healthcare and society and how governance structures can better support those affected by technological change. She also leads the responsible AI review process for the Division of Applied AI Technologies and with the IRB. PART 2 In medicine, we do know that examples of bias and harm from that bias have happened. The most famous case was brought to our attention from Ziad Obermeyer and his colleagues in Science in 2019. It was examining racial discrimination resulting from a commercial algorithm that was widely used by health systems to identify patients with complex health needs that might need extra support. Instead, we found that the algorithm was prioritizing white patients over black patients and was reducing the number of black patients who should have been enrolled in those care management programs by more than half. In some ways, there are pretty easy ways to fix these kinds of biases and problems if we're attuned to them. So once we see them, we can usually fix them. In this case, training the model using active chronic conditions rather than total costs would have significantly reduced bias.  The point is that understanding the social context in which an algorithm is developed and is operating in is really important. Otherwise, it can be pretty easy to make mistakes like this if you're not paying attention to disparate impacts in the ways that our choices in algorithm development can have impacts on fairness and outcomes for different groups. Another major ethics consideration touched upon in her presentation is mostly about data privacy.

Dr. Kellie Owens, is an assistant professor in the section of medical ethics at NYU Grossman School of Medicine. She's a sociologist and empirical bioethicist studying how digital technologies are woven into the fabric of healthcare and society and how governance structures can better support those affected by technological change. She also leads the responsible AI review process for the Division of Applied AI Technologies and with the IRB. Part 1 Dr. Owens began by indicating that by AI, she means any computer system that's designed to perform tasks that typically require human intelligence, which could be things like recognizing patterns, interpreting data, making predictions, or even making decisions. In the health care context, that means AI systems that analyze complex. medical data that assist with diagnosis or risk prediction that can help automate some routine processes.  She wants to talk mostly about the less fun side, the sort of limitations and potential harms that we have to be aware of to make sure that we're using this technology responsibly. Her focus today is on the people and process side of AI integration and not the technical side. Examples raised today focus specifically on health care implementation. She indicated that there are increasing calls from AI developers and users and regulators and folks in ethics to increase evidence standards for implementing new AI systems. The majority fall outside of FDA regulation, which means they really haven't undergone any formal review for safety and efficacy. The stated goals of ambient documentation, ambient scribes, are to give doctors more time with their patients or more time with their families. We are going to have to vigorously defend that time savings. Otherwise, that free time will be used in plenty of ways that don't touch the problem of physician burnout at all. She wants to be really intentional about how we think about time savings and efficiency regarding AI.

What if a single urine sample could screen for 50 diseases before you ever felt sick? Dejan Nenov, co-founder of AI diagnostics company Luventix, joins Dr. Joy Kong to explain how.Dejan Nenov has spent nearly a decade navigating FDA processes and clinical trials, and also founded Panaton, a healthcare IT company connecting hospitals, labs, and clinics across the US. Luventix uses machine learning to analyze 38,250 raw chemical data points in a single urine sample, identifying disease patterns without isolating a specific biomarker first. Its ongoing IRB-approved study covers roughly 1,250 patients across colorectal cancer, Crohn's, celiac disease, and SIBO. The same model can predict which patients will respond to a given treatment, a tool called companion diagnostics, and could eventually screen for dozens to hundreds of conditions from one low-cost sample. Dejan and Dr. Joy also cover the regulatory pathway for AI diagnostics, including the FDA's Lab Developed Test framework, and how genetics and metabolomics offer two different, complementary pictures of health.The conversation also covers a personal case: a close friend's daughter whose rare condition took years and specialists across ten states to diagnose, and why Dejan believes AI could have caught it sooner.Dr. Joy and Dejan close with what a fully AI-run hospital already looks like in China, and Dejan's vision for an at-home test, like a pregnancy test, that catches disease three to eighteen months before symptoms start.Dejan talks about:00:00 How a dog's nose inspired Luventix03:58 A dog's nose as a gas chromatograph04:22 Training AI to classify disease05:25 The 450-patient GI cancer trial06:54 Urine reflects the body's metabolic state08:07 Skipping biomarkers, reading raw data patterns11:00 38,250 data points per urine sample13:22 Metabolomics plus genetics, a fuller picture16:44 The single 50-disease urine panel18:51 FDA pathways: PMA vs. lab-developed tests22:20 Regulating AI models that keep improving36:11 Catching disease 18 months earlyAdditional Resources✨ Learn more about Luventix: https://www.luventix.com/ ✨ Read more about how AI offers an alternative to genetic testing: https://www.luventix.com/blog/ai-offers-alternatives-to-genetic-testing-to-make-disease-detection-more-accessible Visit My Clinic: Chara Health

Naturopathic gastroenterologist Mark Davis, ND (FABNG), discusses his work in fecal microbiota transplantation (FMT), research, and integrative approaches to GI disease. Davis explains FMT history, screening criteria, delivery methods, how it differs from probiotics, and why it is highly effective for recurrent C. difficile (about a 90% durable cure), while noting FDA-approved products (Rebyota, Vowst) and off-label applications. He describes IRB-approved studies on naturopathic care for IBS and ulcerative colitis and a blinded project comparing consistency across 15–20 stool microbiome labs. The conversation covers evidence for diet in IBS/IBD (including SCD and a semi-vegetarian diet), low-FODMAP as a temporary tool, breath testing and relapse in SIBO, helminthic therapy options and legality, targeted probiotics (Saccharomyces boulardii, Akkermansia, soil-based species), enema therapies, indigo naturalis benefits and risks, saffron evidence for mood, telemedicine practice, and a crowdfunding platform for clinical trials.

Send us Fan MailStruggling to find participants for your dissertation? In this episode of Dissertation Deconstructed, Dr. Denise Nixon shares practical, ethical, and effective strategies for recruiting participants for quantitative research studies. Learn how to increase survey response rates, recruit in rural and island communities, avoid common recruitment mistakes, and collect the quality data you need to successfully complete your dissertation. Whether you're preparing for IRB approval or launching your survey, this episode will help you recruit with confidence.Music by Moses Harris from Pixabay Music by Krzysztof Szymanski from PixabaySubscribe & Follow the Show!https://denisenixon.comLinkedin: https://www.linkedin.com/in/denisenixon/Podcast Disclaimerhttps://denisenixon.com/podcast-disclaimer/

2026-07-24 In this episode of TGIF-DTRA, hosts Jane Myles, Craig Lipset, and Dr. Amir Kalali are joined by Donna Parker and Christoph Hornick from Duke University's iCubed to explore Project Loom, an initiative testing how agentic AI can support clinical trial operations.The conversation covers where AI excelled, drafting protocols, informed consent forms, IRB submissions, and case report forms, and where it struggled, including participant pre-screening. The guests discuss what these findings mean for the future of clinical research, the critical role of human oversight, and how AI could help make trial design and execution more accessible.The episode also explores cybersecurity, workforce implications, and the growing need for standards to evaluate AI quality and interoperability across clinical research.You can join TGIF-DTRA Sessions live on LinkedIn Live on Friday's at 12:00 PM ET by checking out our LinkedIn. Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and X. Learn more about Membership options and our work at www.dtra.org.

A good research idea is not always a good research question. Bruno Hochhegger, MD, PhD, speaks with host Amit Gupta, MD, about choosing research questions that are clinically relevant, feasible, and worth pursuing in real-world settings. Listen to their discussion in episode 1 of The Early Career Researcher's Playbook, an AJR Podcast Series. Full article: https://www.ajronline.org/doi/10.2214/AJR.26.35586 *Key Takeaways Defining Clinical Relevance: A strong research question must answer a direct patient management issue, such as determining if a nodule is benign or malignant. The Feasibility and Sustainability Matrix: Moving from simple case reports to professional science requires navigating EMRs, securing IRB authorizations, and finding reliable grant funding. The AI Implementation Trap: While building artificial intelligence models on GitHub has become more accessible, adequately validating these tools for real-world clinical practice remains a massive, frequently underestimated hurdle. Multidisciplinary Research Networks: True feasibility requires nonmedical input; successful projects demand early feedback from IT departments, technologists, and referring surgeons to ensure workflows survive reality. *Key Moments 00:00 Intro and Welcome 01:18 The Importance of Small Steps: Lessons from a Failed MRI Lung Cancer Screening Trial. 04:30 Defining Clinical Relevance and the Crucial Role of the Physician-Researcher. 07:47 Assessing Feasibility: Navigating EMRs, IRB Approvals, and Data Access. 08:45 Research Sustainability: Securing Grants and Transitioning from Voluntary to Professional Science. 10:50 The AI Feasibility Trap: Why Validating Models is Harder Than Coding on GitHub. 16:08 Identifying the Key Indication: Solving Direct Patient Management Questions. 21:51 Beyond Mentorship: Building a Network Across IT, Technologists, and Referring Clinicians. 28:51 Establishing Niche Expertise: Strategic Advice for Radiology Residents and Fellows Follow AJR on Social Media LinkedIn: https://www.linkedin.com/showcase/ajr-radiology/ YouTube: https://www.youtube.com/channel/UCfFAYezkLMxJGMgIJLN0Dpg Instagram: https://www.instagram.com/ajr_radiology/ TikTok: https://www.tiktok.com/@ajr_radiology X: https://x.com/AJR_Radiology BlueSky: https://bsky.app/profile/ajrradiology.bsky.social Threads: https://www.threads.com/@ajr_radiology *These portions of the page were generated using artificial intelligence (Google Gemini) and then reviewed for accuracy.

Mike Hutchinson from Arccoss Golf joins us with extensive research from their massive database of golf shots. Our main topic is uncovering what causes double bogeys the most and how they translate to scoring potential across all handicap levels. We think you'll be surprised by the results. Thank you to our show sponsors, For Wellness, Monarch, LMNT, and CashApp Golfers who care about their game should care about taking care of their bodies too. The Good Stuff from For Wellness is a small scoop that can be added to coffee, smoothies, or protein shakes, with ingredients like collagen for joint support, L-theanine for focus, MCTs for energy, cinnamon for antioxidants, and Himalayan salt for minerals and electrolytes. For Wellness conducted an IRB-approved study showing up to an 85% reduction in joint stiffness in 60 days, and the brand has over 12,000 five-star reviews. Sweet Spot listeners can get the best price on a 90-day subscription and welcome kit at ⁠⁠forwellness.com/sweetspot⁠⁠ with promo code SWEETSPOT for an extra 10% off. • Monarch is a personal finance app that helps track everything in one place — accounts, investments, savings goals, and spending. Instead of only showing what has already been spent, Monarch helps users plan ahead, map out bigger purchases, monitor cash flow, and see whether they're actually on track. Features like AI Insights, the Weekly Recap, and the AI Assistant can help flag spending changes, upcoming expenses, and patterns that are easy to miss. Sweet Spot listeners can get their first year of Monarch Core for half off — just $50 — with promo code SWEETSPOT. Visit: ⁠monarch.com • As the weather gets warmer, staying properly hydrated on the golf course becomes even more important. LMNT's new Lemonade Iced Tea flavor combines electrolytes, magnesium, and potassium with no sugar or questionable sports drink ingredients, plus caffeine from black tea extract for a steadier energy boost. Because the caffeine comes from tea, it's naturally paired with L-theanine and polyphenols, which can feel smoother than the spike-and-crash effect of many energy drinks. For golfers looking for hydration and a little back-nine energy, this is a great option to try. With any purchase you're going to get a free sample pack. To claim your special offer visit ⁠⁠⁠drinklmnt.com/sweetspot • Download Cash App Today ⁠⁠by visiting this link⁠⁠ New Cash App customers can earn $10 if they use code CASHAPP10 in their profile at signup and send $5 to a friend within 14 days. Terms apply.  Cash App is a financial services platform, not a bank. Banking services provided by Cash App's bank partner(s). Prepaid debit cards issued by Sutton Bank, Member FDIC. Cash App Visa® Debit Flex Cards issued by Sutton Bank, Member FDIC, and The Bancorp Bank, N.A., pursuant to a license from Visa U.S.A. Inc. See terms and conditions for the Sutton prepaid card, Sutton debit flex card, and Bancorp debit flex card. Cash App Green features, Savings, Direct deposit, Round ups, Overdraft coverage and Discounts provided by Cash App, a Block, Inc. brand. Visit cash.app/legal/podcast for full disclosures. Learn more about your ad choices. Visit megaphone.fm/adchoices

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to discuss the company's receipt of written FDA feedback and central Institutional Review Board (IRB) approval, with modifications, for its optimized Phase 2 clinical trial evaluating Teverelix® in men following a first episode of acute urinary retention (AUR). Bokhari said the randomized, double-blind, placebo-controlled, multicenter study, designated ANT-2111-02, will enroll approximately 126 patients to evaluate the effects of Teverelix DP, a long-acting GnRH antagonist, on prostate volume and urinary function after an initial episode of AUR. The FDA provided seven recommendations related to protocol implementation, safety monitoring, and study documentation, including updates to contraception reporting, injection-site blinding, alpha-blocker therapy tracking, race data collection, and clarification of a secondary endpoint. Importantly, Bokhari said the company believes the FDA's comments are operational in nature and can be addressed through protocol amendments without changing the study's scientific rationale, patient population, treatment arms, primary endpoint, or planned interim analysis. Medicus is now working with its regulatory, clinical, and contract research partners to incorporate both the FDA and IRB recommendations, finalize participating clinical sites, and complete the remaining start-up activities ahead of patient enrollment. Management believes the regulatory feedback represents another important milestone in advancing Teverelix as a potential treatment for men experiencing acute urinary retention associated with enlarged prostate disease. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Teverelix #ClinicalTrials #FDA #Biotech #Phase2 #Urology #DrugDevelopment #HealthcareInnovation #PharmaNews

Viena no daudzajām diskusijām tikko aizvadītajā sarunu festivālā „Lampa” bija veltīta kultūras saistībai ar pilsonisko līdzdalību. Arī pētījumi liecina, ka profesionālā māksla var veicināt empātiju, savstarpējo sapratni un spēju apzināties savu lomu sabiedrībā. Vai mākslinieki par to domā apzināti un kā šo mākslas vērtību iedzīvināt izglītības vidē? Par to saruna Kultūras rondo. Vai mākslas darbs ir arī īsceļš uz sabiedrībai nozīmīgiem jautājumiem skolā? Kultūras norises, izglītība un pilsoniskā līdzdalība. Tāpēc sarunā vairāk par praktiskām kultūras norisēm skolās un to, ko piedāvā jauna programma "Latvijas skolas somā". Sarunājas un iepazīstina māksliniece Eva Vēvere, kura darbojas ar sabiedriskiem projektiem kultūras, veselības, integrācijas jomā, ir pieredze Latvijas Laikmetīgās mākslas centra projektos "Mākslinieks ir klātesošs", programmas "Latvijas skolas soma" vadītāja Aija Tūna un Izglītības attīstības centra programmu autore un lektore, Draudzīgā Aicinājuma Cēsu Valsts ģimnāzijas skolotāja Ingūna Irbīte.  

The Legislature created the Industrial Revenue Bond (IRB) program in 1961 to promote economic development. Local governments issue IRBs to fund business facilities with the goals of growing the local economy and increasing property tax revenue. Businesses that use IRBs can get a 10-year property tax exemption (IRBX). During 2010-2024, local governments issued about $18.3 billion in industrial revenue bonds and exempted about $1.1 billion in related property taxes, most of which would've likely gone to school districts and local governments. Statute requires local governments to prepare cost-benefit analyses (CBAs) if they want to offer IRBXs but provides limited guidance on their quality. We compared foregone property tax revenue estimates in 23 CBAs to the actual foregone property taxes reported by county appraisers. The CBA estimates differed greatly from county appraiser amounts (between 94% lower and 6,065% higher). Some CBAs underestimated completed project values, some overestimated how much investment would translate into appraised value, and some used erroneous figures and assumptions when estimating property taxes.Finally, we identified 3 subsidiaries of foreign businesses that received $282 million in IRB funds in 2024.

Você Sabia é um quadro da Rádio TCE sobre ações envolvendo os TCs. IRB abre consulta pública para aperfeiçoar norma sobre auditoria de prevenção à corrupção até 15 de julho.Edição de som: Bia Rezende Reportagem: Lu Zoccoli

Send us Fan MailYour IRB has been approved, your study is ready to go—but no one is responding. Now what?In this episode of Dissertation Deconstructed, Dr. Denise Nixon shares practical, ethical strategies for recruiting participants for qualitative research. Learn what to consider before launching your study, what to do when recruitment stalls, how to increase participation without violating IRB requirements, common mistakes to avoid, and why staying connected with your dissertation chair can make all the difference. If participant recruitment is delaying your dissertation, this episode will help you get back on track with confidence.Music by Moses Harris from Pixabay Music by Krzysztof Szymanski from PixabaySubscribe & Follow the Show!https://denisenixon.comLinkedin: https://www.linkedin.com/in/denisenixon/Podcast Disclaimerhttps://denisenixon.com/podcast-disclaimer/

In this episode we explore what we would do differently if we had the chance to start golf over again with all the knowledge we have now. Thanks to our show sponsors For Wellness, Strike Wedge, Monarch, and Ultra Pouches: For Wellness is a small scoop that can be added to coffee, smoothies, or protein shakes, with ingredients like collagen for joint support, L-theanine for focus, MCTs for energy, cinnamon for antioxidants, and Himalayan salt for minerals and electrolytes. For Wellness conducted an IRB-approved study showing up to an 85% reduction in joint stiffness in 60 days, and the brand has over 12,000 five-star reviews. Sweet Spot listeners can get the best price on a 90-day subscription and welcome kit at ⁠⁠forwellness.com/sweetspot⁠⁠ with promo code SWEETSPOT for an extra 10% off. • Monarch is a personal finance app that helps track everything in one place — accounts, investments, savings goals, and spending. Instead of only showing what has already been spent, Monarch helps users plan ahead, map out bigger purchases, monitor cash flow, and see whether they're actually on track. Features like AI Insights, the Weekly Recap, and the AI Assistant can help flag spending changes, upcoming expenses, and patterns that are easy to miss. Sweet Spot listeners can get their first year of Monarch Core for half off — just $50 — with promo code SWEETSPOT. Visit: ⁠monarch.com • Most golfers don't need more swing thoughts — they need better feedback on impact. That's what I like about Strike Wedge: it's a simple, portable training aid that helps you work on the three things that matter most for better ball striking — low point control, path, and strike location. You can use towels, bottles, and other DIY setups for some of this, but Strike Wedge puts it all into one tool that fits in your golf bag and makes your practice more organized. If you're trying to improve your contact without overcomplicating your swing, this is a smart training aid to check out. Go to ⁠⁠⁠http://strikewedge.com/sweetspot⁠⁠⁠ to get 15% off • Ultra is the ultimate guilt-free pouch — delivering instant focus and mental clarity, without nicotine or caffeine. New customers can use code SWEETSPOT to get 15% off at https://takeultra.com/⁠⁠https://takeultra.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Co-Host Nicholas Velotta (https://www.mountaintoppodcast.com/arya) My first-time guest Nicholas Velotta is an intimacy researcher for a company called Arya. Arya curates sexual experiences for couples everywhere. Nicholas's IRB-approved study of over 600,000 people found about how guided erotic experiences actually affect long-term attraction and connection. What did the data from couples reveal about the specific communication gap men fall into around desire? Next, discover why attraction doesn't fade on its own, and what the data shows actually triggers or kills it in long-term relationships. What can men specifically do differently to become the partner who keeps attraction alive? Also, find out why structure and novelty (not spontaneity) sustain erotic connection, and what couples can do about it right away. Could it be true that many men have sexual desires or fantasies that they wouldn't tell their "macho" friends about? (You decide...) You'll also get a  breakdown of Arya's "Scenes" (Heat, Taste, Bound, and more), including what they are, how they work, and why couples who use them report deeper intimacy and sustained attraction. Get the free report Flip The Switch: 5 Things You Can Do Right Now To Be Better With Women, and also take the Reality Check Inventory quiz...both at https://mountaintoppodcast.com === HELP US SEND THE MESSAGE TO GREAT MEN EVERYWHERE === This show is built on the "Big Four": Confidence, Masculinity, Liking Women, and Good Character. Better men get better women. If you love what you hear, please rate the show on the service you subscribed to it on (takes one second) and leave a review.

Hace 2.000 millones de años, la aparición de las células eucariotas revolucionó la vida en el planeta y con el tiempo darían lugar a protistas, plantas, hongos y animales. Para explicar su origen, Lynn Margulis propuso en la década de 1960 su teoría endosimbiótica, en la que una célula primitiva engulló a otra, dando origen a las mitocondrias. Seis décadas después, un trabajo liderado por científicos españoles, con la ayuda del supercomputador MareNostrum 5 de Barcelona, confirma que la intuición de Margulis fue acertada, aunque replantea el origen de nuestras células como una historia de alianzas microbianas con actores hasta ahora desconocidos. Hemos entrevistado a Toni Gabaldón, profesor ICREA, director del grupo de Genómica Comparada en el BSC y en el IRB, y líder de la investigación.-Faltan menos de dos meses para el eclipse total de Sol que podremos ver en buena parte de la Península Ibérica y son muchas las iniciativas en marcha. La última, de la Sociedad Española de Astronomía, es “Un mundo de eclipses”, un atlas interactivo sobre las interpretaciones de los eclipses solares en las culturas del mundo. Hemos hablado con Montse Villar, coordinadora del proyecto. Hemos informado de la concesión del Premio Princesa de Asturias de la Concordia 2026 a la astronauta estadounidense Christina Koch por "extender las fronteras de la humanidad, apoyada en un amplio trabajo colectivo". Koch fue miembro de la tripulación de Artemisa II alrededor de la Luna, y durante su estancia en la EEI fue la primera mujer en protagonizar una caminata espacial y la que más tiempo ha permanecido en el espacio. Con Xiomara Cantera, directora de NaturalMente, hemos celebrado los primeros 50 números de esta revista que publica trimestralmente el Museo Nacional de ciencias Naturales, del CSIC. Adeline Marcos nos ha contado el proyecto europeo “Adaptation” para la creación de dispositivos capaces de absorber la energía solar para convertirla en electricidad, y al mismo tiempo, enfriarse por sí solos. Con testimonios de Sara Núñez Sánchez, del Instituto de Ciencia de Materiales de Madrid del CSIC y coordinadora del proyecto. Con Fernando Blasco hemos jugado a un juego de magia matemática con una baraja de cartas, basado en múltiplos del nueve. Escuchar audio

Hace 2.000 millones de años, la aparición de las células eucariotas revolucionó la vida en el planeta y con el tiempo darían lugar a protistas, plantas, hongos y animales. Para explicar su origen, Lynn Margulis propuso en la década de 1960 su teoría endosimbiótica, en la que una célula primitiva engulló a otra, dando origen a las mitocondrias. Seis décadas después, un trabajo liderado por científicos españoles, con la ayuda del supercomputador MareNostrum 5 de Barcelona, confirma que la intuición de Margulis fue acertada, aunque replantea el origen de nuestras células como una historia de alianzas microbianas con actores hasta ahora desconocidos. Hemos entrevistado a Toni Gabaldón, profesor ICREA, director del grupo de Genómica Comparada en el BSC y en el IRB, y líder de la investigación.-Faltan menos de dos meses para el eclipse total de Sol que podremos ver en buena parte de la Península Ibérica y son muchas las iniciativas en marcha. La última, de la Sociedad Española de Astronomía, es “Un mundo de eclipses”, un atlas interactivo sobre las interpretaciones de los eclipses solares en las culturas del mundo. Hemos hablado con Montse Villar, coordinadora del proyecto. Hemos informado de la concesión del Premio Princesa de Asturias de la Concordia 2026 a la astronauta estadounidense Christina Koch por "extender las fronteras de la humanidad, apoyada en un amplio trabajo colectivo". Koch fue miembro de la tripulación de Artemisa II alrededor de la Luna, y durante su estancia en la EEI fue la primera mujer en protagonizar una caminata espacial y la que más tiempo ha permanecido en el espacio. Con Xiomara Cantera, directora de NaturalMente, hemos celebrado los primeros 50 números de esta revista que publica trimestralmente el Museo Nacional de ciencias Naturales, del CSIC. Adeline Marcos nos ha contado el proyecto europeo “Adaptation” para la creación de dispositivos capaces de absorber la energía solar para convertirla en electricidad, y al mismo tiempo, enfriarse por sí solos. Con testimonios de Sara Núñez Sánchez, del Instituto de Ciencia de Materiales de Madrid del CSIC y coordinadora del proyecto. Con Fernando Blasco hemos jugado a un juego de magia matemática con una baraja de cartas, basado en múltiplos del nueve. Escuchar audio

The episode explores why golfers should not expect to feel fully comfortable on the course, especially under pressure, and how accepting nerves, bad swings, or lingering fears can help keep a round together. There is also a debate about whether golfers should tee the ball up on par threes, which is tied to a larger conversation about margin for error, reducing big mistakes, and testing what works best for your own game. Finally, the episode covers how on-course personality affects performance, and why finding the right balance between focus on the ball and staying relaxed between shots can be a major unlock for both scoring and enjoyment. Thanks to our show sponsors Lagoon Sleep, For Wellness, Strike Wedge, Rhoback, Ridge, and LMNT Lagoon Sleep helps you find the right pillow for your sleep position and body type with a quick two-minute quiz, giving you a more personalized setup for better rest and recovery. Their adjustable pillows are trusted by elite athletes and can help with neck support, cooling, and waking up without aches or pains. Sweet Spot listeners can get 15% off by going to lagoonsleep.com/sweetspot and using promo code SWEETSPOT. • Golfers who care about their game should care about taking care of their bodies too. The Good Stuff from For Wellness is a small scoop that can be added to coffee, smoothies, or protein shakes, with ingredients like collagen for joint support, L-theanine for focus, MCTs for energy, cinnamon for antioxidants, and Himalayan salt for minerals and electrolytes. For Wellness conducted an IRB-approved study showing up to an 85% reduction in joint stiffness in 60 days, and the brand has over 12,000 five-star reviews. Sweet Spot listeners can get the best price on a 90-day subscription and welcome kit at ⁠⁠⁠⁠forwellness.com/sweetspot⁠⁠⁠⁠ with promo code SWEETSPOT for an extra 10% off. • Most golfers don't need more swing thoughts — they need better feedback on impact. That's what I like about Strike Wedge: it's a simple, portable training aid that helps you work on the three things that matter most for better ball striking — low point control, path, and strike location. You can use towels, bottles, and other DIY setups for some of this, but Strike Wedge puts it all into one tool that fits in your golf bag and makes your practice more organized. If you're trying to improve your contact without overcomplicating your swing, this is a smart training aid to check out. Go to ⁠⁠http://strikewedge.com/sweetspot⁠⁠ to get 15% off • Rhoback makes some of the best golf apparel we've worn. Their polos are incredibly comfortable with moisture-wicking fabric, plenty of stretch, and a crisp collar that works on and off the course. They're got a couple of new releases for spring - the Highlands Hoodie—lightweight with great mobility for golf—and the Brookline Vest, a perfect layering piece for cooler tee times. Get 20% off your first order ⁠⁠⁠⁠⁠https://rhoback.com/⁠⁠⁠⁠⁠ using promo code SWEET. • As the weather gets warmer, staying properly hydrated on the golf course becomes even more important. LMNT's new Lemonade Iced Tea flavor combines electrolytes, magnesium, and potassium with no sugar or questionable sports drink ingredients, plus caffeine from black tea extract for a steadier energy boost. Because the caffeine comes from tea, it's naturally paired with L-theanine and polyphenols, which can feel smoother than the spike-and-crash effect of many energy drinks. For golfers looking for hydration and a little back-nine energy, this is a great option to try. With any purchase you're going to get a free sample pack. To claim your special offer visit ⁠⁠drinklmnt.com/sweetspot • The Ridge Wallet is a slim, modern alternative to bulky leather wallets, designed to fit comfortably in your front pocket while still holding up to 12 cards and cash. Made with premium materials like aluminum, titanium, and carbon fiber, Ridge wallets include RFID-blocking technology, a lifetime warranty, and over 50 colors and styles to choose from — making them a great Father's Day gift. For a limited time, get up to 40% off during Ridge's Father's Day Sale at Ridge.com/sweetspot, and after you purchase, let them know we sent you. Learn more about your ad choices. Visit megaphone.fm/adchoices

Truth Be Told with Booker Scott – Patients reporting vaccine injuries deserve honest diagnosis, transparent research, and care guided by data. Clinicians pursue decentralized trials, IRB review, and promising treatments while families seek answers. Medical freedom, accountability, and compassion drive a call to fund studies, publish results, and ensure injured Americans are not ignored or unjustly dismissed...

NM manages to squeak out a gain to 49th in Kids Count. Paul and Wally discuss the latest numbers. NM has an $850 million oil and gas windfall, but New Mexicans won't see any of that. MLG is proud of our higher education ranking? Bernalillo County is looking to offer $1.2 billion in IRB's for a massive West Side solar facility.   New Mexico's Chamber of Commerce issued a report that provides sound ideas for economic reform. ABQ City Council to reconsider a gross receipts tax hike for a swimming pool and possibly place it on the ballot for this fall. RGF has an opinion piece on the LFC study on economic development incentives. Paul provides a recap on the Foundation's recent event with Anastasia Boden.  Paul is heading to SE New Mexico for a series of talks.

In this episode, Jon and Adam discuss a simple but more useful way to track golf stats without getting buried in apps or misleading numbers like fairways hit and total putts. Jon explains how golfers can evaluate tee shots, approach shots, wedge play, and putting with a basic checkmark/X system focused on whether shots were functional, playable, and connected to scoring. The larger message is that stat tracking only matters if it leads to a better post-round review: identifying good shots, spotting real patterns, and separating ball-striking issues from strategy or mental-process mistakes. The episode also includes a follow-up conversation with Jared Tendler about self-doubt, anxiety, and why golfers do not need perfect confidence to improve or compete well. Ultimately, the discussion encourages golfers to review their rounds with more clarity, less emotion, and a stronger focus on the patterns that actually hold them back.   Purchase Jared Tendler's new book, Everyday Golf Psychology ⁠here⁠ Join the free community Jared created around the book ⁠here Thank you to our show sponsors, Strike Wedge, For Wellness, Rhoback, Warby Parker, and Pestie Golfers who care about their game should care about taking care of their bodies too. The Good Stuff from For Wellness is a small scoop that can be added to coffee, smoothies, or protein shakes, with ingredients like collagen for joint support, L-theanine for focus, MCTs for energy, cinnamon for antioxidants, and Himalayan salt for minerals and electrolytes. For Wellness conducted an IRB-approved study showing up to an 85% reduction in joint stiffness in 60 days, and the brand has over 12,000 five-star reviews. Sweet Spot listeners can get the best price on a 90-day subscription and welcome kit at ⁠⁠⁠forwellness.com/sweetspot⁠⁠⁠ with promo code SWEETSPOT for an extra 10% off. • Most golfers don't need more swing thoughts — they need better feedback on impact. That's what I like about Strike Wedge: it's a simple, portable training aid that helps you work on the three things that matter most for better ball striking — low point control, path, and strike location. You can use towels, bottles, and other DIY setups for some of this, but Strike Wedge puts it all into one tool that fits in your golf bag and makes your practice more organized. If you're trying to improve your contact without overcomplicating your swing, this is a smart training aid to check out. Go to ⁠http://strikewedge.com/sweetspot⁠ to get 15% off • Rhoback makes some of the best golf apparel we've worn. Their polos are incredibly comfortable with moisture-wicking fabric, plenty of stretch, and a crisp collar that works on and off the course. They're got a couple of new releases for spring - the Highlands Hoodie—lightweight with great mobility for golf—and the Brookline Vest, a perfect layering piece for cooler tee times. Get 20% off your first order ⁠⁠⁠⁠https://rhoback.com/⁠⁠⁠⁠ using promo code SWEET. • Warby Parker Sport gives you performance eyewear that actually looks like something you'd want to wear every day, with no-slip nose pads, lightweight frames, wraparound designs, glare-reducing lenses, and 100% UVA/UVB protection. They're built for golf, tennis, pickleball, running, hiking, coaching kids' sports, or just staying active without your sunglasses sliding, fogging, or distorting your vision. Right now, our listeners can buy one pair of glasses and get 20% off any additional pairs at WarbyParker.com/sweetspot • Pestie makes pest control simple by giving you a DIY kit with the pro-grade treatment, sprayer, mixing bag, gloves, and instructions you can complete in less than 10 minutes. Each plan is customized to your location, season, bugs, and climate, so you can protect your home year-round without waiting around for contractors, dealing with service windows, or signing expensive contracts. Fix your bug problem before it gets worse — go to https://pestie.com/SWEETSPOTS for 10% off your order. Learn more about your ad choices. Visit megaphone.fm/adchoices

At sixteen, with straight A's in math and science, Dr. Karen Panetta's school career assessment told her to sell makeup or be a cook. A male friend with lower scores got engineer or politician. No AI was involved. Just a rules-based system applying gender and biographical filters to two teenagers. That same logic now sits inside AI tools landing in admissions offices and HR systems across higher ed, with one critical difference: AI does not eliminate human bias, it removes the human accountability that used to make bias correctable. In this episode of the Changing Higher Ed® podcast, Dr. Drumm McNaughton speaks with Dr. Karen Panetta, Dean of Graduate Education for the School of Engineering at Tufts University and an IEEE Fellow. Panetta lays out a procurement framework presidents and boards can use to evaluate AI tools before signing a contract. She and McNaughton work through the four questions most vendors cannot answer, why IRB principles already give higher ed a working framework for AI, and what happens to graduate research when students ask AI for a unique contribution and accept whatever comes back. This conversation is especially relevant for institutional leaders making decisions about AI procurement, classroom adoption, and data governance who want a clear set of questions to ask before they buy and a clear standard for keeping humans accountable for the decisions AI tools are increasingly being asked to make. Topics Covered: The four procurement questions every higher ed leader should ask before signing an AI contract Why expert disagreement on ground truth limits what any AI tool trained on that judgment can do How IRB principles apply to AI deployments, and why every kind use of technology has a misuse case sitting next to it The risk of AI's interpretation of truth aging with the consensus Why faculty in English, history, and the arts are essential to AI policy What IEEE's 500,000 technical professionals are doing on AI standards that no single corporate vendor will do Real-World Examples Discussed: The career assessments that pointed a top math student toward cooking and a Navy veteran toward forest ranger work A cancer detection project where six doctors agreed on whether something was cancer but disagreed on every grade beyond that A conservation project where the same tracking data that helps park rangers could help poachers if security is weak Graduate admissions committees where different faculty weight credentials, projects, and volunteer work differently, and what gets lost when only one set of weights is encoded into an AI screen Three Key Takeaways for Leadership: AI does not create bias. It scales whatever bias is already in the institution's decision systems, at the speed and volume the institution chose to deploy. Every consequential decision needs a human in the loop who can explain the call out loud. Without that, the institution cannot defend the decisions it is making. The sticker price on the AI tool is not the story. The data behind it is, and most vendors cannot tell you what it is. This episode gives presidents, provosts, and boards a practical framework for AI procurement and governance, along with a clear answer to the trustee asking why the institution has not bought what everyone else is buying. Read the transcript: https://changinghighered.com/ai-bias-procurement-framework-higher-education/ #HigherEducation #AIinHigherEd #HigherEducationPodcast #AIGovernance #AIBias #HigherEducationLeadership

In this episode, we take a deep dive into one of golf's most misunderstood words: consistency. Adam and Jon unpack why consistency is not about making the exact same swing every time, but rather learning how to manage variability, improve impact patterns, and build bigger margins for error. They discuss why golfers often make themselves less consistent by trying to control too much, and how external focus, differential practice, smarter strategy, and better expectations can all help. If you've ever wondered why your good shots and bad shots can show up in random order, this episode will give you a much clearer framework for understanding what consistency really means in golf. Thank you to our show sponsors, For Wellness, Strike Wedge, Ethos, Rhoback, and LMNT Golfers who care about their game should care about taking care of their bodies too. The Good Stuff from For Wellness is a small scoop that can be added to coffee, smoothies, or protein shakes, with ingredients like collagen for joint support, L-theanine for focus, MCTs for energy, cinnamon for antioxidants, and Himalayan salt for minerals and electrolytes. For Wellness conducted an IRB-approved study showing up to an 85% reduction in joint stiffness in 60 days, and the brand has over 12,000 five-star reviews. Sweet Spot listeners can get the best price on a 90-day subscription and welcome kit at ⁠⁠forwellness.com/sweetspot⁠⁠ with promo code SWEETSPOT for an extra 10% off. • Most golfers don't need more swing thoughts — they need better feedback on impact. That's what I like about Strike Wedge: it's a simple, portable training aid that helps you work on the three things that matter most for better ball striking — low point control, path, and strike location. You can use towels, bottles, and other DIY setups for some of this, but Strike Wedge puts it all into one tool that fits in your golf bag and makes your practice more organized. If you're trying to improve your contact without overcomplicating your swing, this is a smart training aid to check out. Go to http://strikewedge.com/sweetspot to get 15% off • Rhoback makes some of the best golf apparel we've worn. Their polos are incredibly comfortable with moisture-wicking fabric, plenty of stretch, and a crisp collar that works on and off the course. They're got a couple of new releases for spring - the Highlands Hoodie—lightweight with great mobility for golf—and the Brookline Vest, a perfect layering piece for cooler tee times. Get 20% off your first order ⁠⁠⁠⁠⁠https://rhoback.com/⁠⁠⁠⁠⁠ using promo code SWEET. • As the weather gets warmer, staying properly hydrated on the golf course becomes even more important. LMNT's new Lemonade Iced Tea flavor combines electrolytes, magnesium, and potassium with no sugar or questionable sports drink ingredients, plus caffeine from black tea extract for a steadier energy boost. Because the caffeine comes from tea, it's naturally paired with L-theanine and polyphenols, which can feel smoother than the spike-and-crash effect of many energy drinks. For golfers looking for hydration and a little back-nine energy, this is a great option to try. With any purchase you're going to get a free sample pack. To claim your special offer visit ⁠drinklmnt.com/sweetspot • Protect your family's financial future with life insurance through ⁠⁠Ethos⁠⁠. Ethos makes the process simple and 100% online—you can get a quote in seconds and apply in as little as 10 minutes, with coverage options up to $3 million and some policies starting around $30 per month. There's no medical exam required—just answer a few health questions online to get started. Learn more and get your free quote at ⁠⁠https://ethos.com/SWEETSPOT Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of the NTI PodTalk, Dianne chats with NTI instructor, Megan Grover. They discuss chronic stress, burnout, and the role herbal medicine can play in supporting resilience and recovery. Megan explains the science behind adaptogens, like ashwagandha, and discusses how chronic stress impacts the nervous system, immune health, sleep, hormones, and digestion. They also discuss the realities of modern burnout culture, and practical strategies for supporting emotional regulation and nervous system balance. In today's fast-paced, high stress world, the information in this episode is so relevant and beneficial for anyone. Tune in to learn how to build resilience with herbs and reduce your stress. About Megan Grover:Megan Grover is a nutrition scientist and educator, based in New York City. With a Master of Medical Science in Human Nutrition from the University of Sheffield and over a decade of experience bridging science, education, and public health, Megan has built her career on translating complex nutritional science into actionable strategies. As the former Director of Education and Research at a growing wellness company, Megan led clinical research initiatives, served as the Principal Investigator on IRB-approved studies, and supported product development. She also created and oversaw the nutrition continuing education department for integrative nutrition coaches and dietitians, and managed all science-facing content across the organization.Megan teaches multiple nutrition science classes at NTI and previously served as a full-time professor of human anatomy, physiology, and nutrition at the university level. She started MBG Wellness to address a critical gap she observed throughout her career: driven executives and professionals were experiencing burnout despite outward success. Through corporate wellness programming, Megan delivers the nutrition education, strategic support, and science-backed interventions that enable teams to sustain performance without sacrificing wellbeing.Connect with Megan:MBG WellnessInstagramSubstackLinkedIn**Timestamps for the topics discussed can be found on this episode's NTI PodTalk page,Are you ready to start your journey as a Nutrition Therapist Master? To learn more about NTI's Nutrition Therapist Master Certification, visit ntischool.com for more information, or call 303-284-8361 to speak with our admissions team.This discussion is not intended to provide Medical Nutrition Therapy, nor in any way imply that Nutrition Therapists who graduate from NTI are qualified to provide Medical Nutrition Therapy. The scope of practice for graduates of NTI is to deliver therapeutic nutrition guidance to our clients which helps support their natural biology to achieve optimal function in whatever wellness path they are on.

In this episode, we discuss how to spend whatever time you have before your round productively. Whether it's 5 minutes or 45 minutes, you'll get ideas for warming up effectively without falling into common traps. Thank you to our show sponsors Monarch, Ultra Pouches, For Wellness, and Rhoback Golfers who care about their game should care about taking care of their bodies too. The Good Stuff from For Wellness is a small scoop that can be added to coffee, smoothies, or protein shakes, with ingredients like collagen for joint support, L-theanine for focus, MCTs for energy, cinnamon for antioxidants, and Himalayan salt for minerals and electrolytes. For Wellness conducted an IRB-approved study showing up to an 85% reduction in joint stiffness in 60 days, and the brand has over 12,000 five-star reviews. Sweet Spot listeners can get the best price on a 90-day subscription and welcome kit at ⁠forwellness.com/sweetspot⁠ with promo code SWEETSPOT for an extra 10% off. • Monarch is a personal finance app that helps track everything in one place — accounts, investments, savings goals, and spending. Instead of only showing what has already been spent, Monarch helps users plan ahead, map out bigger purchases, monitor cash flow, and see whether they're actually on track. Features like AI Insights, the Weekly Recap, and the AI Assistant can help flag spending changes, upcoming expenses, and patterns that are easy to miss. Sweet Spot listeners can get their first year of Monarch Core for half off — just $50 — with promo code SWEETSPOT. Visit: monarch.com • Ultra Sleep Pouches are designed to help users wind down, fall asleep faster, stay asleep, and wake up without next-morning grogginess. They use six research-backed ingredients, including properly dosed melatonin, L-theanine, magnesium, chamomile, passionflower, and lemon balm, creating a more complete sleep-support system than many typical sleep aids. They're easy to use — just place one pouch in your mouth before bed — and the formula is designed for better, deeper sleep without building tolerance. New customers can get 15% off at https://takeultra.com/ with the show's promo code SWEETSPOT • Rhoback makes some of the best golf apparel we've worn. Their polos are incredibly comfortable with moisture-wicking fabric, plenty of stretch, and a crisp collar that works on and off the course. They're got a couple of new releases for spring - the Highlands Hoodie—lightweight with great mobility for golf—and the Brookline Vest, a perfect layering piece for cooler tee times. Get 20% off your first order ⁠⁠⁠⁠https://rhoback.com/⁠⁠⁠⁠ using promo code SWEET. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us Fan MailThe IRB process can feel intimidating, confusing, and filled with endless revisions—but it doesn't have to derail your dissertation journey. In this episode of Dissertation Deconstructed, Dr. Nixon breaks down how to successfully prepare for IRB review, avoid common mistakes, and navigate revisions with confidence. Learn the essential dos and don'ts of the IRB application process, why working closely with your dissertation chair matters, and why conducting research before approval can seriously delay your progress.Drawing from experience chairing over 50 doctoral committees, this episode also shares real insight, encouragement, and practical strategies to help doctoral students move through the process with clarity and confidence. Plus, a heartfelt reflection on recently watching five students earn their doctorates—and the joy of calling them “Doctor” for the very first time.Music by Moses Harris from PixabaySubscribe & Follow the Show!http://www.denisenixon.comLinkedin: https://www.linkedin.com/in/denisenixon/Podcast Disclaimerhttps://denisenixon.com/podcast-disclaimer/

Scott is offering a 30% discount on both DECADE Elite and DECADE Foundations for Sweet Spot listeners. Use promo code sweetspot on the DECADE website: ⁠⁠https://decade.golf/⁠⁠ Also, ⁠⁠this link⁠⁠ will automatically apply the coupon code. In Part 2 of our conversation with Scott Fawcett from DECADE Golf, we shift from shot shaping into how golfers can actually prepare to score better. Scott shares what he's focusing on as he gets ready for tournament golf, including 20- to 40-foot speed control, basic chip-shot practice, and avoiding the mistakes that lead to big numbers. We also get into a debate on block versus random practice, why so many golfers struggle to take their range game to the course, and how a better pre-shot routine can improve commitment. This episode is all about practicing with more intention and turning your existing game into lower scores. Thank you to our sponsors, For Wellness and LMNT Golfers who care about their game should care about taking care of their bodies too. The Good Stuff from For Wellness is a small scoop that can be added to coffee, smoothies, or protein shakes, with ingredients like collagen for joint support, L-theanine for focus, MCTs for energy, cinnamon for antioxidants, and Himalayan salt for minerals and electrolytes. For Wellness conducted an IRB-approved study showing up to an 85% reduction in joint stiffness in 60 days, and the brand has over 12,000 five-star reviews. Sweet Spot listeners can get the best price on a 90-day subscription and welcome kit at forwellness.com/sweetspot with promo code SWEETSPOT for an extra 10% off. As the weather gets warmer, staying properly hydrated on the golf course becomes even more important. LMNT's new Lemonade Iced Tea flavor combines electrolytes, magnesium, and potassium with no sugar or questionable sports drink ingredients, plus caffeine from black tea extract for a steadier energy boost. Because the caffeine comes from tea, it's naturally paired with L-theanine and polyphenols, which can feel smoother than the spike-and-crash effect of many energy drinks. For golfers looking for hydration and a little back-nine energy, this is a great option to try. With any purchase you're going to get a free sample pack. To claim your special offer visit drinklmnt.com/sweetspot Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us Fan MailDr. Surabhi Aggarwal, neonatologist at Stony Brook University, joins Ben and Rupa to share five years of experience building a LISA — Less Invasive Surfactant Administration — program from the ground up at her institution. She walks through the obstacles of getting IRB approval, gaining clinical buy-in from colleagues comfortable with intubation, and how the introduction of video laryngoscopy was the turning point that finally got the practice off the ground. She shares early results showing that 30% of eligible babies received surfactant via LISA rather than intubation, discusses the technical nuances of catheter placement and confirmation, and weighs in on the emerging SALSA technique using an LMA — with a candid admission that she may be a little biased. She also highlights her work with MidCan, the AAP mid-career neonatologist group supporting clinicians between seven and seventeen years post-training.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

In this episode of PRIM&R's podcast, "Research Ethics Reimagined," we explore the inclusion of individuals with disabilities in research with Nancy Olson, JD, IRB. Olson serves as an analyst at the University of Nebraska Medical Center and is the recipient of PRIM&R's 2024 Service Award. Drawing on more than two decades of experience in human research protections and her own lived experience as a person who became deaf, Olson discusses how assumptions about disability shape — and often limit — who gets to participate in research. She examines the responsibilities of both researchers and IRBs in designing accessible studies and calls for a shift from compliance-focused thinking to genuine participant-centered preparation. 

Brīnumains izgudrojums, kas vieglāks par gaisu un kam tika paredzēts nākotne pārvadāt pasažierus pāri okeānam. Dirižabļi aviācijas nozarei kalpoja gan par tehnoloģisku sasniegumu, gan rūgtu mācībstundu. Kā sākās un beidzās dirižabļu laikmets pasaulē? Par to runājam ar Rīgas Aeronavigācijas institūta direktoru Ilmāru Blumbergu un Latvijas Kara muzeja Ieroču un militārās tehnikas nodaļas vadītāju Daini Poziņu. Piedāvājam arī nelielu pārskatu par Latvijas nacionālas aviācijas attīstību – dažus pieturpunktus, jo, lai arī runa ir par īsu laika posmu, sākot no atsevišķiem interesentiem un viņu konstruētajiem aparātiem 20. gs. 20. gados līdz  rūpnīcai VEF, kur lidmašīnu būve beidzās 1942. gadā, vienā raidījumā visu mūsu aviobūves vēsturi nevar ietilpināt.  Runājot par vienotu aviācijas būvi Latvijas Republikā, flagmanis bija rūpnīca VEF, kur no 1935. līdz 1942. gadam tika izgatavotas 33 dažādu tipu lidmašīnas. Protams, nacionālā lidmašīnu būve mums saistās ar konstruktora Kārļa Irbīša vārdu, bet bez viņa ir jāmin vēl vesela rinda aviācijas būves speciālistu: Kārlis Švarcbahs, Kārlis Jansons, lidotājs un konstruktors Kārlis Bandenieks, galdnieks Žanis Knauke, metālists Kārlis Ozoliņš, metinātājs Feldmanis un citi. Pagājušā  gadsimta 20. gados parādās vairāki lidmašīnu konstruktori, kas intereses un prieka pēc sāk nodarboties ar  gaisa kuģu būvi, Talsos dzimušais avio konstruktors un lidotājs Nikolajs Pūliņš, zināmais lidotājs Herberts Cukurs un dedzīgais Kārlis Irbītis, kuru jau no zēnības ir aizrāvušas lidmašīnas. 1932. gadā Irbītis strādā jaunizveidotajā Valsts elektrotehniskajā fabrikā mehānikas nodaļā. Un par to, kā Irbīša idejas tika ieviestas VEF, stāsta VEF muzeja krājuma glabātāja Dace Kaprāne. Atgriežoties pie VEF pirmajiem lidmodeļiem un to tapšanu, kā savās atmiņas atceras Kārlis Irbītis, mūsu lidotājs Bandenieks jeb, kā mēs viņu saucām, «Bandiņš» kā sadedzis gribēja tūliņ sākt lidmašīnu mēģināt. „Atļāvu Bandiņam tomēr mazliet «pavīlēt» pa aerodromu. Viņš tad arī ar jauno lidmašīnu paskraidīja pa aerodromu, bet nenocietās un mazliet atrāva lidmašīnas riteņus no zemes. Atpakaļ pieskaršanās, par nelaimi, notika sagāztā stāvoklī uz vienu skrietuli, un tā tika ielocīta uz iekšu.” Citāta beigas. Protams – kad lidmašīna bija pilnībā izgājusi testu un atzīta par labu esam, tad arī lidojumi notika bez aizķeršanās. Mūsu lidaparāti devās arī pāri Latvijas robežām, lidmašīnas piedalās dažādās sacensībās Francijā un Anglijā, starptautiskā aviācijas izstādē Cīrihē. Bet, lai arī VEF īsais avioperiods izklausās kā veiksmes stāsts, tomēr tajā ir arī viena melna lappuse. Lidmašīnu būvi VEF uzsāka 1935. gadā un līdz 1942. gadam izgatavoja 33 dažādu tipu lidmašīnas. Kā saprotams, 1940. gadā rūpnīcas teritorijā saimnieko padomju iebrucēji un pēc tam turpmākos divus gadus te vēl gatavo lidaparātus vācu armijas vajadzībām.  

What if the biggest barrier to better healthcare outcomes is… the blood draw itself? In this episode, Web Golinkin, President at Babson Diagnostics, discusses how his company is reinventing blood testing with a patient-friendly, fingertip-based system. He explains why traditional venipuncture drives anxiety and non-adherence, and how BetterWay improves both experience and outcomes. He also shares how automation and simplified workflows reduce operational burden and expand access points for care. Finally, he explores why patient experience is becoming the key competitive differentiator in ambulatory healthcare. Tune in to learn how rethinking a decades-old process could unlock better care, better business, and better patient engagement. About Web Golinkin: Web Golinkin has focused his career on making health information and care more accessible and affordable. He has done this as CEO of five companies over the past 35 years, including three he co-founded. These companies include the largest cable TV network devoted to health (America's Health Network), one of the nation's largest operators of retail-based clinics (RediClinic), a leading population health management company (Health Dialog), and one of the nation's largest operators of urgent care clinics (FastMed). Web also co- founded the Convenient Care Association and served as its Chair for many years. He has been widely covered in the national media and has spoken at numerous healthcare conferences. Things You'll Learn: Blood testing drives around 70% of medical decisions but has not fundamentally changed in decades. About one-third of patients skip testing due to discomfort or inconvenience. BetterWay uses a fingerstick method and requires 90% less blood. The system eliminates the need for a phlebotomist, enabling more flexible staffing. Automated sample preparation reduces errors and manual workload. The approach is backed by extensive validation, including IRB studies and peer-reviewed data. With an NPS of 79, compared to negative industry scores, it delivers a significantly better patient experience while supporting ambulatory growth, reducing leakage, and improving chronic disease management. Resources: Connect with and follow Web Golinkin on LinkedIn, visit his website, or reach out via email. Follow Babson Diagnostics on LinkedIn and explore their website. Learn more about BetterWay here.

#314 What if chronic constipation, gut dysbiosis, and microbial imbalance were early warning signs of Parkinson's disease — appearing up to 20 years before a diagnosis? In this episode, I sit down with microbiome researcher and founder of The BioCollective, Martha Carlin, whose journey into Parkinson's research began when her husband John was diagnosed at just 44 years old. Martha spent over two decades studying the gut-brain connection in Parkinson's, building one of the first independent IRB-approved human microbiome research initiatives in the world. In this episode, you'll discover: Why chronic constipation can precede a Parkinson's diagnosis by 20+ years — and why it is never normal The two phenotypes of Parkinson's disease and how gut bacteria can distinguish between them The role of hydrogen sulphide, LPS endotoxins, and leaky gut in Parkinson's pathology The mycobacteria connection to Parkinson's that almost nobody is talking about How glyphosate is decimating the good bacteria we need most The glycocalyx — what it is, why it matters, and how to restore it The overlooked cardiovascular risks in Parkinson's disease. Where to start if you or someone you love has just received a diagnosis If you are living with chronic constipation, have a family member with Parkinson's, or want to understand the deeper gut-brain connection — this episode is for you.   Find Martha at biotiquest.com    I'm Lynda Griparic, a degree-qualified naturopath specialising in complex gut health conditions, including SIBO, IMO, and chronic constipation. Book a consultation or shop BetterMe Tea at lyndagriparic.com

Anne Walling, MB ChB, joins the Faculty Factory Podcast this week to discuss some incredible stories of resilience she uncovered while researching her new book "Women in Medicine: Stories from the Girls in White." Dr. Walling interviewed 37 women who fought for credibility, worked harder than is almost imaginable, and graduated from medical school between 1948 and 1975. She wanted to learn why they went into medicine and how their experiences unfolded throughout medical school, residency, and entry into practice. The work was conducted by Dr. Walling as formal qualitative research with IRB oversight and open-ended questions. She joined us at the Faculty Factory for her second interview on our show to share the stories and insights she gathered. You can learn more about the book here: https://www.routledge.com/Women-in-Medicine-Stories-from-the-Girls-in-White/Walling/p/book/9781032873190 Dr. Walling is Professor Emerita at the University of Kansas School of Medicine—Wichita and is also the author of "Academic Promotion for Clinicians: A Practical Guide to Promotion and Tenure in Medical Schools." Learn about that book here: https://link.springer.com/book/10.1007/978-3-031-84036-4 As mentioned, this is her second appearance on our show. You can listen to her first appearance “Episode 334 – A Deep Exploration of Academic Promotions for Clinicians with Anne Walling, MB ChB,” here: https://facultyfactory.org/anne-walling/

Artificial Intelligence in Medical Education: Opportunities, Risks, and GuardrailsIn this episode of The Pediatric Lounge, the hosts welcome back Dr. Rani Gareige, director of medical education and designated institutional official at Nicklaus Children's Hospital and a clinical professor at Florida International University, to discuss artificial intelligence in medical education now and in the future. They preview Nicklaus Children's Hospital's 61st annual postgraduate pediatrics CME conference in Fort Lauderdale (Hilton Marina Resort, March 20–22), highlighting sessions on IBD, short stature, dermatology, psychological screening, AI in practice management, social media communication, genetic testing/personalized medicine, and Florida's new requirement for EKG screening to clear athletes starting ninth grade. The conversation covers common AI tools learners use (ChatGPT, Claude, OpenEvidence) and institutional concerns about HIPAA/PHI, including blocking public tools and using a secure in-house system (“Ask Nick”) and closed or constrained approaches (e.g., tools that search only approved sources or documents provided, such as Google Notebook). They explore concerns about de-skilling and when to introduce AI in training, faculty development needs, and a precepting framework (DEFT-AI: Diagnosis, Evidence, Feedback, Teaching, and Recommendations for AI use) to assess clinical reasoning. The episode also discusses AI for simulated patient interactions (bad news delivery, motivational interviewing), ambient AI scribing pilots, clinician responsibility to review notes, and AI-driven coding that may reduce undercoding and administrative burden. The discussion concludes that AI will not replace physicians, but clinicians who use AI wisely may replace those who do not, stressing the importance of policies, ethics, transparency, and maintaining empathy and the art of medicine.00:00 Podcast Intro and Guest02:25 CME Conference Details03:13 Hot Topics and New Laws04:44 EKG Screening Program07:42 AI Tools in Training11:42 IRB and Data Privacy14:39 Meeting Minutes Automation16:48 Closed Models for Clinicians19:13 AI Hallucinations and References24:16 Deskilling and Timing AI30:11 Teaching Frameworks for AI32:46 Back to Evidence Basics33:40 Questioning the Evidence34:48 AI and Human Empathy37:45 AI as Clinical Assistant41:01 Recertification in the AI Era46:32 Ethics and Prompting50:40 AI Scribing and Guardrails54:35 Coding and Care Gaps57:15 Future of Medical Education01:01:13 Virtual Trials and Wrap-Up01:0Support the show

In this episode, Evan H. Hirsch, MD welcomes Troy Roach, a citizen scientist and educator, to discuss the revolutionary use of low-dose nicotine patches in the treatment of Long COVID. Troy Roach, originally from California and a graduate of Virginia Tech, works as a Medical English teacher for nursing and physiotherapy students at two universities in Madrid, Spain. After being severely debilitated by COVID-19 in March 2020, with his functional capacity reduced to approximately 30 percent, Troy dedicated himself to Long COVID as a citizen scientist. He joined the Renegade Research community, including Remission Biome, and spearheaded an observational study in 2023 on the use of low-dose nicotine patches for the condition. This study analyzed data from 231 participants, with the results published alongside Dr. Leitzke in 2025. Troy is currently preparing for a longitudinal, IRB-approved follow-up study aimed at further developing evidence-based recovery strategies for Long COVID. In this episode, you'll learn: Why nicotine patches differ from smoking or vaping How the cholinergic system and vagus nerve are involved in Long COVID What the "toxic five" are and how they relate to recovery Safe dosing strategies, brands, and protocols used by thousands Why some patients experience "remission events" after just a few doses Key risks, detox reactions, and how to prepare the body for nicotine use Learn more about Troy's work, community and resources: Blog: https://unitedstatesian.blogspot.com/   Main Resources: https://linktr.ee/thenicotinetest . We help you resolve your Long Covid and Chronic Fatigue (ME/CFS) by finding and fixing the REAL root causes that 95% of providers miss. Learn about these causes and how we help people like you, Click Here. Do you have fatigue, brain fog, shortness of breath, muscle pain, or other strange symptoms? You might have Long Covid. Take our free quiz to find out if Long Covid is behind the mystery symptoms you're experiencing, Click Here. For more information about Evan and his program, Click Here.   Prefer to watch on Youtube? Click Here.   Please note that any information in this episode is for educational purposes only and does not constitute medical advice.

In this episode of PRIM&R's podcast, "Research Ethics Reimagined," we explore the ethical and methodological complexities of suicide and self-harm research with Matthew Nock, PhD, the Edgar Pierce Professor of Psychology at Harvard University and former chair of the Harvard IRB. Dr. Nock discusses how research demonstrates that asking about suicide does not increase risk, the importance of IRB-researcher collaboration, and the challenges of real-time monitoring and intervention with high-risk participants. He shares insights from developing consensus guidelines on ethical conduct of suicide research and emphasizes the critical need for advancing this often-stigmatized field of study.

Neoborn Caveman unpacks a pro-humanity critique of agency loss and non-consensual testing, exposing the 2016 21st Century Cures Act's Section 3024 allowing waiver of informed consent for minimal risk clinical investigations, ties it to MK Ultra experiments and DARPA tech like nanobots or neuralinks, warns of hidden implications in COVID vaccines and digital IDs enabling mass surveillance and control, questions government ethics in bypassing human rights for profit, and urges awareness to counteract manufactured consent through unity and truth.Music guests: pMadKey TakeawaysInformed consent waivers erode human rights.Minimal risk criteria enable unethical experiments.Government acts prioritize profit over safety.Historical abuses like MK Ultra persist today.Vaccines and tech risk non-consensual alterations.Digital IDs facilitate total control.Awareness counters manufactured narratives.Unity protects against elite agendas.Truth demands questioning authority.Humanity requires vigilance for freedom.Sound Bites"Chronical testing of investigational medical devices and drugs no longer requires the informed concern to subjects if the testing poses no more than minimal risk for the subject and includes safeguards.""In 2016, President Obama instituted the 21st Century Cures Act and it was sold for American citizens as a way of fight an opioid epidemic crisis.""It is legal to experiment on American citizens without their consent as long it does not exceed minimal risk criteria.""This provision modifies the investigational drug and device statutory authorities to allow for waver or alteration of informed concern""Prior to the Act HHS Human Subject Regulations permitted an IRB to waive or alter informed concern for certain low-risk research while a federal food drug and Cosmetic Act, FDCA did not contain a similar provision.""it is already happening so how can you stop it? Well evil only is afraid of darkness is scared scared of what?""talk about it. Think about it. Question it. Could be? Should it be? How would we?""when you feel this never ends is it your feeling or is it a generated manufactured feeling"Join the tea house at patreon.com/theneoborncavemanshow—free to enter, real talk, lives, no ads, no algorithms.keywords: 21st century cures act, section 3024, informed consent waiver, non-consensual testing, mk ultra, darpa experiments, covid vaccines, digital ids, agency loss, human rightsHumanity centered satirical takes on the world & news + music - with a marble mouthed host.Free speech marinated in comedy.Supporting Purple Rabbits.Viva los Conejos Morados. Hosted on Acast. See acast.com/privacy for more information.

Dr. Chris Goss (Medicine, Pediatrics; Associate Dean for Clinical Research) discusses ways faculty can partner with industry to fund clinical research, serving their patients with cutting-edge science. Dr. Goss recommends working with your department and the UW Clinical Trials Office who can help with the entire study process including conversations with industry partners, IRB questions, and site-specific resources. He walks through the timeline and responsibilities involved with being a principal investigator in a clinical trial and provides tips for how to be successful amidst common bottlenecks and challenges. Clinical research at UW has grown significantly and may be an excellent pathway for faculty looking to diversify their research funding.Learn about the UW Clinical Trials Office here.Music by Kevin MacLeod (https://incompetech.com/)

Gabe Charalambides is the founder of Odyssey, the world's leading provider of psilocybin-assisted therapy, and a Stanford-trained aerospace engineer whose personal experience with anxiety helped shape a mission: making psychedelic healing safer, more responsible, and more accessible to everyday people. After years working alongside leading psychedelic organizations, Gabe launched Odyssey in 2023 and helped open the first legal psilocybin retreat in the U.S., rooted in screening, preparation, and evidence-based support.In this conversation, we explore what psilocybin therapy can look like when done responsibly—why education, intention-setting, and integration matter as much as the ceremony itself. Gabe explains how psilocybin may reduce mental rigidity, increase psychological flexibility, and help people move through trauma, rumination, and fear—especially the existential distress that can come with a cancer diagnosis. We also break down what a guided experience typically involves (screening, preparation sessions, a full-day facilitated journey, and post-session integration), what outcomes Odyssey is tracking through an IRB-approved study, and why many participants describe their experience as one of the most meaningful of their lives.If you've been curious about psychedelics but unsure what “safe” really means—or you're navigating chronic illness, anxiety, or trauma and looking for new tools—this episode offers a grounded, practical look at what's real, what's promising, and what to consider before taking the next step. To learn more, visit https://www.odysseypbc.com/Key Topics CoveredGabe's background: Stanford-trained aerospace engineer → founder of OdysseyHow anxiety, OCD, and meditation shaped his approach to mental healthWhy psilocybin can help “unstick” rigid thought patterns and emotional loopsWhat a safe, legal psilocybin-assisted therapy process looks like (screening → prep → session → integration)“Set and setting” explained: why environment and support dramatically change outcomesSpiritual and psychological effects people commonly report (connection, meaning, reduced fear of death)Microdosing vs. full-dose therapy: differences, evidence, and expectationsSafety considerations: contraindications, unpleasant experiences, and why support mattersOdyssey's IRB-approved outcomes study and what they're measuring (wellbeing, anxiety, flexibility, mindfulness)How this work may support cancer patients facing existential distress and fear -----------------------------------------------A Better Way to Treat Cancer: A Comprehensive Guide to Understanding, Preventing and Most Effectively Treating Our Biggest Health ThreatGrab my book here: https://www.amazon.com/dp/B0CM1KKD9X?ref_=pe_3052080_397514860 Unleashing 10X Power: A Revolutionary Approach to Conquering CancerGet it here: https://store.thekarlfeldtcenter.com/products/unleashing-10x-powerPrice: $24.99100% Off Discount Code: CANCERPODCAST1 Healing Within: Unraveling the Emotional Roots of CancerGet it here: https://store.thekarlfeldtcenter.com/products/healing-withinPrice: $24.99100% Off Discount Code: CANCERPODCAST2-----------------------------------------------Integrative Cancer Solutions was created to instill hope and empowerment. Other people have been where you are right now and have already done the research for you. Listen to their stories and journeys and apply what they learned to achieve similar outcomes as they have, cancer remission and an even more fullness of life than before the diagnosis. Guests will discuss what therapies, supplements, and practitioners they relied on to beat cancer. Once diagnosed, time is of the essence. This podcast will dramatically reduce your learning curve as you search for your own solution to cancer. To learn more about the cutting-edge integrative cancer therapies Dr. Karlfeldt offer at his center, please visit www.TheKarlfeldtCenter.com

Jordy shares school-camp carnage with teacher-turned-radio-host Jay Reeves sending kids into heavy surf on an IRB, a touch-footy tackle that ended in a hip replacement, and childhood antics digging a car-swallowing trap on the family beach track.#propertrueyarn Hosted on Acast. See acast.com/privacy for more information.

his podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com A fingertip-sized blood sample may soon replace the needle stick millions of patients avoid every year. In this episode, Web Golinkin, President of Babson Diagnostics, shares how Better Way, a fingertip blood collection system, is redefining convenience, accuracy, and accessibility in diagnostic testing. He explains how the company spent nearly a decade validating its technology through 45+ IRB-approved studies, 4,300+ participants, and more than 850,000 tests to ensure clinical equivalence to venous draws. He traces the innovation's journey from a Siemens skunkworks project to partnerships with BD and a 510(k)-cleared device, culminating in an 80% primary-care test menu from a pea-sized sample. He also highlights how Better Way improves adherence, enhances patient and staff experience, and reduces friction with clear, graphical results. Tune in and discover how fingertip testing can transform preventive care, patient engagement, and healthcare operations! Resources Connect with and follow Web Golinkin on LinkedIn. Follow Babson Diagnostics on LinkedIn and visit their website!

In this powerful and eye-opening episode of The Super Human Life, Coach Frank Rich sits down with longevity pioneer and author Dr. Jeffrey Gladden, founder of Gladden Longevity and a leading voice in human performance optimization.   Together, they challenge the cultural belief that aging is an inevitable decline and reveal how mindset, biology, technology, and purpose all intersect to determine how long (and how well) we live.   Dr. Gladden shares why aging is more of a mindset than a biological certainty, how purpose and spirituality directly impact health, and why the "questions you ask yourself" may be one of the most underrated longevity tools we possess.   The conversation dives deep into the nervous system, emotional fitness, relationships, AI advancements, and the future of biohacking, giving men a roadmap to living younger, stronger, and more intentionally for decades to come.   This is not a conversation about resisting aging. This is a conversation about redefining what's possible for the human experience.   Episode Highlights & Takeaways Aging is a mindset, not a destiny. Your beliefs about aging directly influence your biology and lifespan. Define your longevity goals early. Intentionality shapes the habits and systems that determine how well you age. Spirituality & purpose are longevity multipliers. Living aligned with meaning strengthens resilience, vitality, and emotional health. AI will revolutionize personalized health optimization. When used correctly, it can supercharge diagnostics, protocols, and prevention. The nervous system determines your youthfulness. Stress, trauma, and dysregulation accelerate aging more than most people know. Biohacking tools can support, but not replace foundational health. Tech is a supplement, not the solution. Your relationships shape your mental and physical longevity. Deep connection and emotional safety reduce biological aging markers. The quality of your questions defines the quality of your life. Better questions → better decisions → better outcomes. A fulfilling life is built on love and creation. Purpose, generosity, service, and self-expression deepen well-being at every age. Guest Bio:  Dr. Jeffrey Gladden Dr. Jeffrey Gladden is a visionary in human longevity, advanced performance, and regenerative health. A triple-board-certified interventional cardiologist turned longevity expert, Dr. Gladden spent decades at the forefront of cardiac innovation, co-founding the Heart Hospital Baylor Scott & White and developing leading cardiac programs across the country.   But it was his own battle with fatigue, brain fog, and declining vitality that pushed him to rethink traditional medicine and pursue a deeper truth: aging is not a fixed fate — it's a process we can influence, optimize, and even reverse.   Today, as the founder of Gladden Longevity, he leads a cutting-edge clinic that helps individuals "live young for a lifetime" through personalized diagnostics, breakthrough technologies, and his signature Symphony of Longevity framework. His bestselling book, 100 Is the New 30, challenges conventional beliefs about aging and explores what's truly possible when a person optimizes body, mind, purpose, and spirit.   Through his research, IRB-approved clinical trials, and global speaking, Dr. Gladden is on a mission to answer one profound question:   "How good can you be—physically, mentally, emotionally, and spiritually—as you age?"   --- Connect with Frank and The Super Human Life on Social Media: Instagram: https://www.instagram.com/coachfrankrich/   Facebook: https://www.facebook.com/groups/584284948647477/   Website: http://www.thesuperhumanlifepodcast.com/tshlhome   YouTube: https://www.youtube.com/channel/UCjB4UrpxtNO2AFtDURMzoKQ  

Inside the SMHP Research Academy: How Practitioners Can Turn Real-World Results Into Published Science When the Society of Metabolic Health Practitioners (SMHP) launched the Journal of Metabolic Health in late 2023, one question quickly rose to the surface: How do we help frontline clinicians, many of whom have never conducted research, learn to design, run, and publish high-quality studies? Enter Dr. Melanie Tidman. A professor, researcher, and longtime SMHP member, Melanie recognized a gap, and built a solution. The result is the SMHP Research Academy, a fully supported, step-by-step pathway that teaches practitioners how to take research ideas from concept to publication. In this podcast episode, she walks listeners through what the Academy offers, why it exists, and how it's already helping clinicians produce peer-reviewed science. Below is a summary of what you'll hear, but the full interview is worth every minute. A One-of-a-Kind Resource for Practitioners Melanie created the Academy in early 2024 with a clear mission: make research accessible to clinicians working in the real world. "I had the vision back then to create an academy where our members who have never done research before could learn all of the ins and outs… of how to do research, how to collect data, how to analyze that data and how to publish a research article." Over nine months she built a 10-module, self-paced research curriculum, complete with video lessons, customizable learning formats, downloadable notes, and direct faculty support. Members can take the modules in order or revisit individual sections as needed. Each module, she notes, is "completely comprehensive and customizable for your own learning style." IRB Support—Including Up to $3,000 in Savings One of the biggest hurdles for new researchers is the IRB (Institutional Review Board) process. It's required for human studies in the U.S., but few practitioners know how to navigate it, and few are aware that approval often costs between $1,500 and $3,000. Melanie explains the differences between exempt, expedited, and full-board studies and then shares the Academy's unique advantage: "Two of us on the academy faculty are also faculty for universities having access to university IRBs… we become the primary investigator for the purpose of the IRB application… and there is no cost." For members, that alone is a major benefit—one of many. Faculty-Guided Support From Design to Publication The Academy pairs each participant with a research mentor and faculty team specializing in study design, data analysis, manuscript writing, and qualitative methods. Projects now include case reports, retrospective analyses, literature reviews, mixed-methods studies, and more. As Melanie notes, the Academy already has 16 projects underway, including "three articles in peer review right now." She emphasizes that no project is too small: "Say you just have one patient who had an incredible result, and you want to publish… I'm your man." Up to $10,000 in Total Value—Free for SMHP Members When Melanie adds up the typical costs—IRB fees, data-analysis consultation, manuscript editing, and open-access publication fees—she estimates that members receive between $9,000 and $10,000 worth of services at no charge. "If you publish with the Journal of Metabolic Health and you are a member of the SMHP, the SMHP will pay your open-access publishing fees," she explains. "There's another three to four thousand dollars worth of savings." Why This Matters The Academy empowers clinicians, from solo practitioners to large-system physicians, to turn real-world metabolic health outcomes into peer-reviewed evidence. And as Melanie reminds listeners: "I can't say enough about my gratitude… It's there for your benefit. If you are a member, you have an entire Academy worth of information at your fingertips." Learn more about The SMHP™ and join here.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

Why are women hitting perimenopause earlier than ever, and what can you do about it?In this episode, Angela sits down with functional nutritionist and hormone pioneer Alisa Vitti, founder of FLO Living and author of WomanCode and In the FLO, to explore the real reasons modern women are struggling with hormonal balance. You'll learn how stress and poor sleep suppress ovulation, why melatonin is the first hormone to decline in perimenopause, and how to rebuild hormonal resilience through nutrition, strength training, and oxytocin-boosting practices.Alisa also shares her groundbreaking Cycle Syncing® Method, backed by IRB-approved research showing up to 80% symptom reduction in just 30 days. If you want to understand how your hormones, mood, and energy are linked - and how to extend your hormonal youth - this episode is essential. What You'll Learn: • Why stress accelerates hormonal aging and earlier perimenopause • How ovulation acts as a “deposit” into your longevity bank account • Cycle Syncing®: IRB-backed results showing 80% fewer symptoms in 30 days • The midlife nutrition and training blueprint for women • Why oxytocin and nitric oxide are critical for mood, metabolism, and muscle • The hidden downsides of methylene blue and antibacterial mouthwash • Sauna vs. cold therapy: what really benefits women's hormones • How Alisa built FLO Living as a longevity-focused women's health platform • Alisa's daily non-negotiables for hormonal balance Timestamps: 00:00 Intro 01:32 The Stress Epidemic & Earlier Perimenopause 04:40 Ovulation, Cortisol & the Infradian Rhythm 06:06 Cycle Syncing® Clinical Trial: 80% Symptom Reduction 08:42 Why Ovulation = Longevity Deposits 12:28 The First Hormone to Decline: Melatonin 14:34 Midlife Nutrition Shifts: Protein, Carbs & Alcohol 16:00 Strength Training & Midlife Body Composition 28:17 Alisa's Travel Meal-Prep Routine 32:52 Restaurant Pitfalls: Seed Oils, Sodium & Smart Ordering 35:24 Macro Targets: Protein per Meal, Carbs per Day 37:23 Carb Timing for Sleep & HRV 40:38 Oxytocin, Nitric Oxide & Edging Explained 40:52 The Methylene Blue & Mouthwash Mistake 50:37 Cold Exposure vs Sauna for Women 54:42 Building FLO Living & Avoiding Burnout 59:08 Alisa's Non-Negotiables: Food, Movement, Sleep 1:00:27 Where to Find Alisa & FLO Living VALUABLE RESOURCES A BIG thank you to our sponsors who make the show possible: • Carol Bike - Exclusive discount for podcast listeners on Carol Bike - the bike that gets you fittest the fastest - click here http://www.carolbike.com/⁠⁠ and use code ANGELA • Supercharge your energy and upgrade your mitochondria with Mitopure - http://timeline.com/angela | Enter code ANGELA to save 10% ABOUT THE GUEST Alisa Vitti is the founder and CEO of FLO Living and creator of the Cycle SyncingⓇ Method. A leading women's hormone and biohacking expert, she discovered the Infradian Rhythm and authored the bestsellers WomanCode and In the FLO, empowering women to live in sync with their biology.

Have you ever felt the soul of your workplace—the sense of connection, purpose, and community—start to fade? That's exactly what happened to Dr. Sonia Millan, a board-certified family medicine physician with additional certifications in sports and lifestyle medicine. When her autonomy dwindled and joy disappeared, she knew it was time to make a change. Instead of leaping into the unknown with one perfect plan, Sonia earned what she calls her "honorary master's in pivotry." She experimented, explored, and stayed curious—trying everything from chart review and patient advocacy to IRB work and prison-system audits. Some paths fit, others didn't, but each step brought her closer to a career she truly loves. And here's the twist: the job she once thought she'd never enjoy is now her 10-out-of-10 dream role. Her journey is a powerful reminder that clarity doesn't come from waiting for the perfect plan—it comes from moving, experimenting, and letting go of what's not for you. In this episode we're talking about: How losing autonomy in clinical practice led Sonia to explore new possibilities The mindset shift that helped her turn uncertainty into opportunity Unexpected lessons she learned from eight years as a white-water rafting guide How she tested different nonclinical paths (and what she learned from each one) What changed her mind about her current role and why she now loves it How curiosity, intuition, and her "lunch litmus test" helped her find her ideal fit The spiritual practice that keeps her grounded. Links for this episode:

If you’ve ever wondered what the difference is between a Switched Virtual Interface (SVI) and Integrated Routing and Bridging (IRB), today’s show is for you! Ethan Banks and Holly Metlitzky start with some history and the basics of communication between layer 2 and layer 3 and then explain how the concepts of SVI and IRB... Read more »

Other Episodes You Might Like: Previous Episode - The Exercise Crisis Destroying Women's Metabolisms (And How to Fix It with Just 2 Workouts) Next Episode - What's Too Late for Bone Density More Like This - Acute vs Chronic Stress Effects on Cortisol in Menopause and Beyond Resources: Stress Nation book by Justin Hai reveals how cortisol — the misunderstood Master Hormone — is at the center of it all. Join the Hot, Not Bothered! Challenge to learn why timing matters and why what works for others is not working for you. Understand how sleep relates to your hormones, muscle mass and weight loss with Flipping 50 Sleep Yourself Strong. Cortisol is truly the missing link in the conversation about wellness, health, fitness, fatness, sleeplessness, and the optimal body composition We're going to take a look at how cortisol follows a natural rhythm, and what light exposure, movement, and food timing have to do with getting your energy and focus back. We'll talk about why most health trends are focused on sleep and hormones, especially in menopause. If you're struggling about cortisol or want the science-backed information, this episode is for you. Know why cortisol is the missing link. My Guest: Justin Hai is the co-founder of several award-winning wellness companies, including Alastin Skincare (acquired by Galderma), GLO Pharmaceuticals, and Rebalance Health. With a background in industrial design and an MBA from Pepperdine, Justin blends creative vision with real science—holding multiple U.S. patents and has presented to NASA and the Pentagon. He is also a featured expert in the upcoming Amazon Prime documentary sHEALed and a passionate advocate for redefining wellness through the lens of hormonal balance, sleep science, and stress mastery. Questions We Answer in This Episode: 06:00- How did you get so deeply interested in studying cortisol? 07:36 - Why is cortisol high in 2025? 12:17 - What is the value of the double blind IRB (independent review board) studies? 14:24 - What's changed in the last 30 years that's spiking our cortisol now?  23:43 - Tell us about Cushing's. 27:23 - How does social media affect hormones? 30:59 - What are the rebalanced lozenges and how do they work? 34:13 - What's the difference between menopause and adropause?

Participate in this anonymous 20-30-minute survey here: Chapman University StudyThis year, we've partnered with OPEN and Dr. Amy Moors at Chapman University, a leading non-monogamy researcher, to bring a new level of academic rigor to this research!Why participate: This data directly supports advocacy work – previous surveys helped win legal protections in major cities. Eligibility: 18+ and practice any form of consensual non-monogamy (polyamory, open relationships, swinging, relationship anarchy, etc.)Study details: Chapman University IRB approved (IRB No. #26-13). Research questions: Dr. Amy Moors, moors@chapman.edu. IRB concerns: (714) 628-2833 or irb@chapman.edu.Survey LinkParticipation is completely voluntary and anonymous. Please share with your non-monogamous networks – more voices = better data = stronger advocacy!